Blog

Jan 18, 2025, 06:34

Intermittent versus continuous chemotherapy in advanced colorectal cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared on X:

“Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised ‘GISCAD’ trial – Annals of Oncology

Authors: R. Labianca, A. Sobrero, L. Isa, E. Cortesi, S. Barni, D. Nicolella, M. Aglietta, S. Lonardi, D. Corsi, D. Turci, G.D. Beretta, G. Fornarini, E. Dapretto, I. Floriani, A. Zaniboni.

Intermittent FOLFIRI given on a 2 month on-off schedule doesn’t compromise PFS and OS in advanced colon cancer.”

A. Sobrero A. Zaniboni Akhil Santhosh cancer D. Corsi D. Nicolella D. Turci E. Cortesi E. Dapretto G. Fornarini G.D. Beretta I. Floriani L. Isa M. Aglietta OncoDaily Oncology R. Labianca S. Barni S. Lonardi

New Paper Alert: Management of Immune Checkpoint Inhibitor-Associated Toxicities in Older Adults with Cancer

Kimryn Rathmell was Awarded 2025 ACS Medal of Honor

VERITAC-2 Trial Update: Vepdegestrant Meets Primary Endpoint in ESR1-Mutant Breast Cancer

New Paper Alert: HARMONi-2 study of Ivonescimab vs pembrolizumab for PD-L1-positive non-small cell lung cancer

We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!